1: (ROOT (S (SBAR (WHADJP (WRB How) (JJ Upbeat)) (S (NNP Vaccine) (NNP News) (VP (VBD Fueled) (NP (NP (DT a) (NNP Stock) (NNP Surge)) (, ,) (CC and) (NP (WHADVP (DT an) (WRB UproarWhen)) (S (NP (NP (DT the) (NN biotech) (NN company)) (NP (NNP Moderna))) (VP (VBD announced) (PP (ADVP (JJ early)) (PP (IN on) (NP (NNP Monday) (NN morning)))) (NP (NP (JJ positive) (NNS results)) (PP (IN from) (NP (NP (DT a) (JJ small) (, ,) (JJ preliminary) (NN trial)) (PP (IN of) (NP (PRP$ its) (NN coronavirus) (NN vaccine))))))))))))) (, ,) (NP (NP (DT the) (NN company) (POS 's)) (JJ chief) (JJ medical) (NN officer)) (VP (VBD described) (NP (DT the) (NN news)) (PP (IN as) (NP (NP (DT a) (`` `) (JJ triumphant) (NN day)) (PP (IN for) (NP (PRP us)))))) (. .) ('' ')))
2: (ROOT (S (NP (NP (NNP Moderna) (POS 's)) (NN stock) (NN price)) (VP (VBD jumped) (NP (QP (RB as) (JJ much) (IN as) (CD 30)) (NN percent))) (. .)))
3: (ROOT (S (NP (PRP$ Its) (NN announcement)) (VP (VP (VBD helped) (S (VP (VB lift) (NP (DT the) (NN stock) (NN market))))) (CC and) (VP (VBD was) (ADVP (RB widely)) (VP (VBN reported) (PP (IN by) (NP (NP (NN news) (NNS organizations)) (, ,) (PP (VBG including) (NP (DT The) (NML (NNP New) (NNP York)) (NNP Times)))))))) (. .)))
4: (ROOT (S (PP (PP (NP (CD Nine) (NNS hours)) (IN after) (NP (PRP$ its) (JJ initial) (NN news) (NN release))) (: -) (CC and) (SBAR (IN after) (S (NP (DT the) (NNS markets)) (VP (VBD closed)))) (: -)) (NP (DT the) (NN company)) (VP (VBD announced) (NP (NP (DT a) (NN stock) (NN offering)) (PP (IN with) (NP (NP (DT the) (NN aim)) (PP (IN of) (S (VP (VBG raising) (NP (QP (JJR more) ($ than$) (CD 1) (CD billion))) (S (VP (TO to) (VP (VB help) (S (VP (VB bankroll) (NP (NN vaccine) (NN development)))))))))))))) (. .)))
5: (ROOT (S (S (NP (DT That) (NN offering)) (VP (VBD had) (RB not) (VP (VBN been) (VP (VBN mentioned) (PP (IN in) (NP (NP (NP (NNP Moderna) (POS 's)) (NNS briefings)) (PP (IN of) (NP (NNS investors) (CC and) (NNS journalists))))) (NP (DT that) (NN morning)))))) (, ,) (CC and) (S (NP (DT the) (NN company) (NN chairman)) (ADVP (RB later)) (VP (VBD said) (SBAR (S (NP (PRP it)) (VP (VBD was) (VP (VBN decided) (PRT (RP on)) (NP (RB only) (DT that) (NN afternoon)))))))) (. .)))
6: (ROOT (S (PP (IN By) (NP (NNP Tuesday))) (, ,) (NP (DT a) (NN backlash)) (VP (VBD was) (VP (VBN underway))) (. .)))
7: (ROOT (S (S (NP (DT The) (NN company)) (VP (VBD had) (RB not) (VP (VBN released) (NP (DT any) (JJR more) (NNS data))))) (, ,) (IN so) (S (NP (NNS scientists)) (VP (MD could) (RB not) (VP (VB evaluate) (NP (PRP$ its) (NN claim))))) (. .)))
8: (ROOT (S (NP (NP (NP (DT The) (NN government) (NN agency)) (VP (VBG leading) (NP (DT the) (NN trial)))) (, ,) (NP (NP (DT the) (NNP National) (NNP Institute)) (PP (IN of) (NP (NNP Allergy) (CC and) (NNP Infectious) (NNPS Diseases)))) (, ,)) (VP (VBD had) (VP (VBN made) (NP (NP (DT no) (NN comment)) (PP (IN on) (NP (DT the) (NNS results)))))) (. .)))
9: (ROOT (S (CC And) (NP (DT the) (NN stock) (NN sale)) (VP (VBD stirred) (NP (NP (NNS concerns)) (PP (IN about) (SBAR (IN whether) (S (NP (DT the) (NN company)) (VP (VBD had) (VP (VBN sought) (S (VP (TO to) (VP (VB jack) (PRT (RP up)) (NP (NP (DT the) (NN price)) (PP (IN of) (NP (PRP$ its) (NN stock) (NN offering)))) (PP (IN with) (NP (DT the) (NN news))))))))))))) (. .)))
10: (ROOT (S (NP (DT The) (NNP Moderna) (NN episode)) (VP (VBZ is) (NP (NP (DT a) (NN case) (NN study)) (PP (IN in) (SBAR (WHADVP (WRB how)) (S (NP (NP (DT the) (NN coronavirus) (NN pandemic)) (CC and) (NP (NP (DT the) (JJ desperate) (NN hunt)) (PP (IN for) (NP (NNS treatments) (CC and) (NNS vaccines))))) (VP (VBP are) (VP (VBG shaking) (PRT (RP up)) (NP (NP (DT the) (JJ financial) (NNS markets)) (CC and) (NP (NP (DT the) (NN way)) (SBAR (IN that) (S (NP (NP (NNS researchers)) (, ,) (NP (NNS regulators)) (, ,) (NP (NN drug) (NNS companies)) (, ,) (NP (NN biotech) (NNS investors)) (CC and) (NP (NNS journalists))) (VP (VBP do) (NP (PRP$ their) (NNS jobs)))))))))))))) (. .)))
11: (ROOT (S (NP (NP (NN Drug) (NNS companies)) (VP (VBN accustomed) (PP (IN to) (S (VP (VBG releasing) (NP (JJ early) (NNS data)) (S (VP (TO to) (VP (VP (VB attract) (NP (NNS investors))) (CC and) (VP (VB satisfy) (NP (NNS regulators))))))))))) (ADVP (RB suddenly)) (VP (VBP find) (S (NP (PRP themselves)) (VP (VBN accused) (PP (IN of) (S (VP (VBG revealing) (NP (NP (ADJP (RB too) (JJ much))) (, ,) (CC or) (RB not) (JJ enough) (, ,)) (PP (IN by) (NP (DT a) (JJ new) (, ,) (JJR broader) (NN audience))))))))) (. .)))
12: (ROOT (S (NP (NNS Journalists)) (VP (MD may) (VP (VB be) (VP (VBN scolded) (PP (IN for) (S (VP (VBG hyping) (NP (JJ early) (NNS findings))))) (, ,) (SBAR (IN while) (S (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBP ignore) (NP (JJ sketchy) (NNS data)))))) (VP (MD may) (VP (VB be) (VP (VBN blamed) (PP (IN for) (S (VP (VBG missing) (NP (DT the) (NN news))))))))))))) (. .)))
13: (ROOT (S (NP (NP (NNS Scientists)) (SBAR (WHNP (WP who)) (S (VP (VBP take) (NP (NP (DT the) (JJ traditional) (NN time)) (SBAR (S (VP (TO to) (VP (VB gather) (CC and) (VB analyze) (NP (PRP$ their) (NNS data)) (PP (IN for) (NP (NP (NN publication)) (PP (IN in) (NP (JJ mainstream) (NNS journals)))))))))))))) (VP (VBP are) (VP (VBN criticized) (PP (IN for) (S (VP (VBG sitting) (PP (IN on) (NP (JJ lifesaving) (NN information)))))))) (. .)))
14: (ROOT (S (NP (JJ Upstart) (NNS websites)) (VP (VP (VBP beat) (NP (DT the) (NNS journals))) (CC and) (VP (VBP break) (NP (DT the) (JJ usual) (NNS rules))) (PP (IN by) (S (VP (VBG publishing) (NP (NP (JJ unvetted) (NNS studies)) (, ,) (NP (NP (DT some)) (PP (IN of) (NP (JJ dubious) (NN quality))))))))) (. .)))
15: (ROOT (S (CC And) (NP (NNP President) (NNP Trump)) (VP (VBZ uses) (NP (PRP$ his) (JJ bully) (NN pulpit)) (S (VP (TO to) (VP (VB promote) (NP (JJ unproven) (NNS treatments)))))) (. .)))
16: (ROOT (SINV (`` `) (S (NP (PRP You)) (VP (VBP have) (NP (NP (DT these) (JJ wild) (NNS swings)) (, ,) (PP (VBN based) (PP (IN on) (NP (JJ incomplete) (NN information))))))) (, ,) ('' ') (VP (VBD said)) (NP (NP (NP (NNP David) (NNP Maris)) (, ,) (NP (NP (VBG managing) (NN director)) (PP (IN of) (NP (NNP Phalanx) (NNP Investment) (NNPS Partners))))) (, ,) (CC and) (NP (NP (DT a) (JJ longtime) (NN analyst)) (VP (VBG covering) (NP (DT the) (NN pharmaceutical) (NN industry))))) (. .)))
17: (ROOT (S (NP (PRP It)) (VP (VBZ 's) (NP (DT a) (JJ crazy) (, ,) (JJ speculative) (NN environment)) (, ,) (SBAR (IN because) (S (NP (DT the) (NN pandemic)) (VP (VBZ has) (VP (VBN caused) (S (NP (NNS people)) (VP (TO to) (VP (VB want) (S (VP (TO to) (VP (VB believe) (SBAR (IN that) (S (NP (EX there)) (VP (VBZ 's) (VP (VBG going) (S (VP (TO to) (VP (VB be) (NP (DT a) (NN miracle) (NN cure)) (PP (IN in) (NP (DT a) (NN miracle) (NN time) (NN frame))))))))))))))))))))) (. .) ('' ')))
18: (ROOT (S (NP (NP (NP (NNP Moderna) (POS 's)) (NN chairman)) (, ,) (NP (NNP Noubar) (NNP Afeyan)) (, ,)) (VP (VBD defended) (NP (NP (DT the) (NN decision) (S (VP (TO to) (VP (VB open) (NP (DT a) (NN stock) (NN sale)))))) (PP (NP (NNS hours)) (IN after) (S (VP (VBG releasing) (NP (VBN limited) (NNS data))))))) (. .)))
19: (ROOT (S (NP (PRP He)) (VP (VBD said) (SBAR (S (NP (NP (DT the) (NN company) (POS 's)) (NN board)) (VP (VP (VBD had) (VP (VBN been) (VP (VBG considering) (NP (DT an) (NN offering)) (PP (IN before) (NP (NP (NNP Monday) (POS 's)) (NN announcement)))))) (, ,) (CC but) (VP (VBD finalized) (NP (DT the) (NN decision)) (ADVP (RB only) (RB late) (PP (IN in) (NP (DT the) (NN day))))))))) (. .)))
20: (ROOT (S ('' `) (S (NP (PRP It)) (VP (VBD was) (VP (VBN based) (PP (IN on) (S (NP (NP (PRP$ our)) (VP (VBG looking) (PP (IN at) (NP (DT the) (NNS data))))) (CC and) (VP (VBG concluding) (SBAR (IN that) (S (NP (PRP we)) (VP (VBD needed) (S (VP (TO to) (VP (VP (VB have) (S (NP (PRP$ our) (JJ own) (NNS resources)) (VP (VBG going) (PP (IN into) (S (VP (VB develop) (NP (DT this) (NN vaccine)))))))) (CC and) (RB not) (ADVP (RB simply)) (VP (VB wait) (PP (IN for) (NP (NN government) (NNS grants)))))))))))))))) (, ,) ('' ') (NP (PRP he)) (VP (VBD said)) (. .)))
21: (ROOT (S (NP (NNP Moderna)) (VP (VBZ has) (NP (DT a) (NN deal) (S (VP (TO to) (VP (VB receive) (NP (QP (IN up) ($ to$) (CD 483) (CD million))) (PP (IN from) (NP (DT the) (. ..) (NN government))) (S (VP (TO to) (VP (VB pursue) (NP (DT a) (NN vaccine)))))))))) (. .)))
22: (ROOT (S (SBAR (IN While) (S (NP (NNS corporations) (CC and) (NNS scientists)) (VP (VBP are) (PP (IN under) (NP (JJ incredible) (NN pressure) (S (VP (TO to) (VP (VP (VB develop) (NP (DT a) (NN vaccine))) (CC and) (VP (VB raise) (NP (NN money)) (PP (IN for) (NP (NN research) (CC and) (NN manufacturing)))))))))))) (, ,) (NP (NN vaccine) (NNS companies)) (VP (VP (VBP are) (ADVP (RB also)) (VP (VBG vying) (PP (IN for) (NP (NP (NN attention)) (PP (IN from) (NP (NNS investors))))) (PP (IN amid) (NP (DT a) (JJ crowded) (NN field))))) (CC and) (VP (VBP are) (VP (VBG seeking) (S (VP (TO to) (VP (VB lift) (NP (PRP$ their) (NN stock) (NNS prices)) (PP (IN in) (NP (DT a) (JJ global) (NN recession))))))))) (. .)))
23: (ROOT (S (NP (QP (RB Nearly) (DT all))) (VP (VBP are) (VP (VBG trying) (S (VP (TO to) (VP (VP (VB compress) (NP (NP (NP (DT the) (NN timetable)) (PP (IN for) (S (VP (VBG developing) (NP (NNS vaccines)))))) (SBAR (WHNP (WDT that)) (S (ADVP (RB normally)) (VP (VBZ takes) (NP (NP (NNS years)) (, ,) (ADVP (RB sometimes)) (NNS decades) (, ,)) (PP (IN into) (NP (DT a) (NN year) (QP (CC or) (RB so))))))))) (: -) (CC and) (ADVP (RB still)) (VP (VB ensure) (SBAR (IN that) (S (NP (DT the) (NNS vaccines)) (VP (MD will) (VP (VB be) (ADJP (JJ safe) (CC and) (JJ effective)))))))))))) (. .)))
24: (ROOT (S (PP (IN At) (NP (DT the) (JJ same) (NN time))) (, ,) (NP (NP (DT a) (NN torrent)) (PP (IN of) (NP (NN information)))) (VP (VBZ is) (VP (VBG blasting) (PP (IN from) (NP (NP (JJ medical) (NNS journals)) (CONJP (RB as) (RB well) (IN as)) (NP (NML (NN company) (CC and) (NN university)) (NN news) (NNS releases)))))) (. .)))
25: (ROOT (S (NP (NNS Articles)) (VP (VBP are) (VP (VBN posted) (PP (IN on) (NP (NP (ADJP (CC s) (HYPH -) (VBN called)) (JJ preprint) (NNS websites)) (PP (IN of) (NP (NP (NNS studies)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (RB not) (VP (VBN been) (VP (NN pee) (HYPH -) (VBN reviewed) (PP (IN by) (NP (NNS experts)))))))))))) (, ,) (PP (IN unlike) (NP (NP (NNS articles)) (PP (IN in) (NP (JJ mainstream) (UCP (JJ medical) (CC and) (NN science)) (NNS journals))))))) (. .)))
26: (ROOT (S (NP (NP (NNP Clinicaltrial.gov)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ lists) (NP (JJ medical) (NNS studies))))) (, ,)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (QP (DT ,) (CD 673)))) (VP (VBD were) (VP (VBG underway) (PP (IN for) (NP (NP (CD Covi-19)) (, ,) (NP (NP (DT the) (NN disease)) (VP (VBN caused) (PP (IN by) (NP (DT the) (NN coronavirus))))) (, ,))) (PP (IN as) (PP (IN of) (NP (NNP May) (CD 23))))))))) (. .)))
27: (ROOT (S (NP (NN News) (NNS outlets)) (VP (VBP are) (VP (VBG rushing) (S (VP (VP (TO to) (VP (VB stay) (PP (IN on) (NP (NP (NN top)) (PP (IN of) (NP (JJ new) (NNS findings))))))) (, ,) (CC and) (VP (TO to) (VP (VB feed) (NP (NP (DT a) (NN public)) (ADJP (JJ hungry) (PP (IN for) (NP (NP (DT any) (NNS advances)) (PP (IN in) (NP (NP (JJ potential) (NML (NML (NNS treatments)) (CC or) (NML (NN vaccine) (NNS candidates)))) (SBAR (WHNP (WDT that)) (S (VP (VBP hold) (NP (NN promise)) (PP (IN against) (NP (DT the) (ADJP (RB highly) (JJ infectious)) (NN virus)))))))))))))))))) (. .)))
28: (ROOT (S (S (NP (DT Some) (NN news) (NNS organizations)) (VP (MD would) (VP (VB prefer) (S (VP (TO to) (VP (VP (VB maintain) (NP (JJ traditional) (NN practice))) (CC and) (VP (VB ignore) (NP (NP (JJ early) (NNS results)) (PP (IN of) (NP (JJ medical) (NNS studies)))))))) (, ,) (S (VP (VBG waiting) (PP (IN for) (NP (ADJP (NN pee) (HYPH -) (VBN reviewed)) (NNS data)))))))) (CC but) (S (NP (PRP they)) (VP (VBP are) (ADVP (RB also)) (VP (VBG competing) (S (VP (TO to) (VP (VB report) (PP (IN on) (NP (DT the) (JJS latest) (NNS studies))))))))) (. .)))
29: (ROOT (S (ADVP (RB Still)) (, ,) (NP (NNS concerns)) (VP (VBP arise) (ADVP (RB routinely)) (PP (IN about) (NP (NP (NP (DT the) (NN quality)) (PP (IN of) (NP (ADJP (RB rapidly) (VBN posted)) (NNS data)))) (CC and) (NP (NP (DT the) (NNS motivations)) (PP (IN behind) (NP (NNS announcements))))))) (. .)))
30: (ROOT (SBARQ (`` `) (WHADVP (WRB Why)) (SQ (VBZ does) (NP (DT any) (NN company)) (VP (VB release) (NP (JJ early) (NNS data)))) (. ?) ('' ')))
31: (ROOT (S (NP (NNP M.) (NNP Maris)) (VP (VBD asked)) (. .)))
32: (ROOT (S (ADVP (RB Clearly)) (NP (EX there)) (VP (VBZ is) (NP (NP (DT an) (NN appetite)) (PP (IN for) (NP (PRP it))))) (. .)))
33: (ROOT (S (NP (NNS People)) (VP (VBP want) (S (VP (TO to) (VP (VB know) (SBAR (IN that) (S (NP (PRP we)) (VP (VBP are) (VP (VBG making) (NP (NN progress)))))))))) (. .)))
34: (ROOT (S (S (VP (VBG Having) (NP (DT a) (NN vaccine)))) (VP (VBZ is) (NP (NP (DT the) (JJS clearest) (NN way)) (PP (IN to) (NP (NP (DT a) (JJ full) (NN reopening)) (CC and) (VP (VBG putting) (NP (DT this)) (PP (IN behind) (NP (PRP us)))))))) (. .) ('' ')))
35: (ROOT (S (NP (NP (NNP Moderna) (POS 's)) (JJ preliminary) (NNS results)) (VP (VBD were) (ADJP (JJ promising))) (. .)))
36: (ROOT (S (NP (NP (PRP$ Its) (NN vaccine)) (, ,) (NP (NP (DT the) (JJ first)) (SBAR (S (VP (TO to) (VP (VB be) (VP (VBN tested) (PP (IN in) (NP (NNS humans))))))))) (, ,)) (VP (VP (VBD appeared) (S (ADJP (JJ safe)))) (CC and) (VP (VBD stimulated) (NP (NN antibody) (NN production))) (PP (IN in) (NP (DT the) (JJ first) (CD 45) (NN study) (NNS participants)))) (. .)))
37: (ROOT (S (CC And) (PP (IN of) (NP (NP (CD eight)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN undergone) (NP (JJ further) (NN testing)) (ADVP (RB so) (RB far)))))))) (, ,) (NP (DT all)) (VP (VBD produced) (NP (NP (ADJP (RB s) (HYPH -) (VBN called)) (VBG neutralizing) (NNS antibodies)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (MD can) (VP (VB stop) (NP (DT the) (NN virus)) (PP (IN from) (S (VP (VBG invading) (NP (NNS cells))))))) (, ,) (CC and) (VP (MD should) (VP (VB prevent) (NP (NN illness))))))))) (. .)))
38: (ROOT (S (CC But) (NP (EX there)) (VP (VBD were) (NP (NP (DT no) (NNS details)) (: -) (NP (NP (DT no) (NNS charts)) (, ,) (NP (DT no) (NNS graphs)) (, ,) (NP (DT no) (NNS numbers)) (, ,) (NP (NP (NN nothing)) (VP (VBN published) (PP (IN in) (NP (DT a) (NN journal)))))))) (. .)))
39: (ROOT (S (S (VP (VBG Releasing) (NP (JJ sparse) (NNS data)))) (VP (VBZ is) (RB not) (ADJP (JJ unusual)) (PP (IN in) (NP (NP (DT the) (NN biotech) (NN world)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (NNS companies)) (ADVP (RB often)) (VP (VBP present) (NP (JJ early) (NN trial) (NNS results)) (SBAR (NP (NNS months)) (IN before) (S (NP (PRP they)) (VP (VBP are) (VP (VBN published) (PP (IN in) (NP (NNS journals))))))))))))) (. .)))
40: (ROOT (S (NP (ADJP (RB Publicly) (VBN traded)) (NNS companies)) (VP (VBP are) (VP (VBN required) (S (VP (TO to) (VP (VB disclose) (NP (NP (JJ material) (NN information)) (SBAR (WHNP (WDT that)) (S (VP (MD might) (VP (VB lead) (NP (DT an) (NN investor)) (S (VP (TO to) (VP (VB buy) (CC or) (VB sell) (NP (NNS shares))))))))))))))) (. .)))
41: (ROOT (S (NP (DT The) (NN company)) (VP (VBD said) (SBAR (S (NP (NP (JJ federal) (NNS researchers)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBG conducting) (NP (DT the) (NN trial))))))) (VP (MD would) (VP (VB be) (ADJP (JJ responsible) (PP (IN for) (S (VP (VBG submitting) (NP (NP (DT the) (NNS data)) (SBAR (S (VP (TO to) (VP (VB be) (VP (VBN reviewed) (CC and) (VBN published)))))))))))))))) (. .)))
42: (ROOT (S (NP (NNP M.) (NNP Maris)) (VP (VP (VBD said) (SBAR (IN that) (S (NP (PRP he)) (VP (MD would) (VP (VB leave) (NP (PRP it)) (PP (IN to) (NP (NNS regulators))) (S (VP (TO to) (VP (VB decide) (SBAR (IN if) (S (NP (DT the) (NN company)) (VP (VBD had) (VP (VBN acted) (ADVP (RB inappropriately)) (PP (IN in) (S (RB not) (VP (VBG announcing) (NP (DT the) (NN stock) (NN sale)) (ADVP (RBR sooner))))))))))))))))) (, ,) (CC and) (VP (VBD said) (SBAR (IN that) (S (NP (NNS investors)) (VP (MD should) (VP (VB have) (VP (VBN been) (VP (VBN told) (ADVP (RBR earlier)) (SBAR (IN that) (S (NP (DT the) (NN company)) (VP (VBD was) (VP (VBG considering) (NP (DT a) (NN stock) (NN offering)))))))))))))) (. .)))
43: (ROOT (S (S (NP (EX There)) (VP (VBZ 's) (NP (NP (NN something)) (ADJP (JJ wrong) (PP (IN with) (NP (DT that))))))) (, ,) ('' ') (NP (PRP he)) (VP (VBD said)) (. .)))
44: (ROOT (S (NP (NP (NNP Moderna)) (, ,) (VP (VBN based) (PP (IN in) (NP (NP (NNP Cambridge)) (, ,) (NP (NNP Mas) (NNP .))))) (, ,)) (VP (VP (VBD went) (ADJP (JJ public)) (PP (IN in) (NP (CD 2018)))) (CC and) (VP (VBZ has) (VP (VBN been) (NP (NP (DT a) (NN favorite)) (PP (IN of) (NP (NN biotech) (NNS investors)))) (, ,) (PP (VBN given) (NP (NP (PRP$ its) (NN focus)) (PP (PP (IN on) (NP (NP (DT the) (JJ hot) (NN area)) (PP (IN of) (NP (NN immun) (HYPH -) (NN oncology))))) (CC and) (NP (NP (PRP$ its) (NNS partnerships)) (PP (PP (IN with) (NP (NP (NNS companies)) (PP (IN like) (NP (NNP Merck) (CC and) (NNP AstraZeneca))))) (, ,) (CC and) (PP (IN with) (NP (NP (DT the) (NML (NNP Vaccine) (NNP Research)) (NNP Center)) (PP (IN at) (NP (NP (DT the) (NNP National) (NNP Institute)) (PP (IN of) (NP (NP (NNP Allergy)) (CC and) (NP (NNP Infectious) (NNPS Diseases)))))))))))))))) (. .)))
45: (ROOT (S (NP (NP (PRP$ Its) (NN technology)) (, ,) (VP (VBN based) (PP (IN on) (NP (NP (JJ genetic) (NN material)) (VP (VBN called) (S (NP (NN messenger) (NNP RNA) (CC or) (NNP mRNA))))))) (, ,)) (VP (VBZ is) (VP (VBN considered) (S (ADJP (RB highly) (JJ promising))))) (. .)))
46: (ROOT (S (`` `) (S (NP (NNP Messenger) (NNP RNA)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (DT the) (JJ hot) (JJ new) (NNS platforms)))))) (, ,) ('' ') (NP (NP (NNP D.) (NNP Anthony) (NNP Fauci)) (, ,) (NP (NP (NN director)) (PP (IN of) (NP (DT the) (NML (JJ infectious) (NN disease)) (NN institute)))) (, ,)) (VP (VBD said) (PP (IN in) (NP (DT an) (NN interview))) (PP (IN on) (NP (NNP Thursday))) (, ,) (S (VP (VBG adding) (SBAR (IN that) (S (NP (PRP it)) (VP (MD can) (VP (VB be) (VP (VP (VBN adapted) (ADVP (RB quickly)) (S (VP (TO to) (VP (VB produce) (NP (JJ new) (NNS vaccines)))))) (CC and) (VP (VBN scaled) (PRT (RP up)) (ADVP (RB easily))))))))))) (. .)))
47: (ROOT (S (SBAR (IN Although) (S (NP (NNP Moderna)) (VP (VBZ has) (NP (JJ other) (NNS vaccines)) (PP (IN in) (NP (PRP$ its) (NN pipeline)))))) (, ,) (S (NP (NN none)) (VP (VBP have) (VP (VBN come) (PP (IN to) (NP (NN market)))))) (, ,) (CC and) (S (NP (NP (DT the) (NN viability)) (PP (IN of) (NP (NP (PRP$ its) (NN mRNA) (ADJP (NN vaccin) (HYPH -) (VBG making)) (NN platform)) (: -) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (DT the) (NN company)))) (: -)))) (VP (VBZ is) (PP (IN on) (NP (DT the) (NN line))))) (. .)))
48: (ROOT (S (S (NP (PRP It)) (VP (VBZ is) (NP (NP (DT a) (NN fron) (HYPH -) (NN runner)) (PP (IN in) (NP (DT the) (NML (NN coronavirus) (NN vaccine)) (NN race)))))) (, ,) (CC and) (S (NP (PRP$ its) (NN stock)) (VP (VBZ has) (VP (VBN risen) (NP (QP (JJR more) (IN than) (CD 250)) (NN percent)) (PP (IN since) (NP (NP (DT the) (NN beginning)) (PP (IN of) (NP (DT the) (NN year)))))))) (. .)))
49: (ROOT (S (NP (PRP It)) (VP (VBD closed) (NP (NP ($ at$) (CD 69)) (NP (DT a) (NN share))) (PP (IN on) (NP (NNP Friday) (NN afternoon))) (, ,) (ADVP (RB down) (NP (CD 26) (NN percent)) (PP (IN from) (NP (NP (DT a) (JJ high) (NNP Monday)) (NP (QP ($ of$) (CD 87))))))) (. .)))
50: (ROOT (S (NP (NNP D.) (NNP Afeyan)) (VP (VBD acknowledged) (SBAR (IN that) (S (NP (NNS companies)) (VP (VBD were) (ADVP (RB now)) (ADJP (JJ subject) (PP (IN to) (NP (ADJP (ADVP (RB far) (RBR more)) (JJ intense)) (NN scrutiny)))) (PP (IN with) (NP (NP (ADJP (RB so) (JJ much)) (VBG riding)) (PP (IN on) (NP (NP (DT the) (NN outcome)) (PP (IN of) (NP (NN drug) (NN development))))))))))) (. .)))
51: (ROOT (S (`` `) (S (NP (NNS People)) (VP (VBP are) (ADVP (RB basically)) (VP (VBG saying) (PRN (, ,) (S (NP (PRP you)) (VP (VBP know))) (, ,)) (SBAR (S (NP (PRP one)) (VP (MD should) (`` ') (RB t) (VP (VB do) (NP (DT this))))))))) (, ,) ('' ') (NP (NNP D.) (NNP Afeyan)) (VP (VBD said)) (. .)))
52: (ROOT (SBARQ (CC And) (SBAR (IN if) (S (NP (PRP you)) (VP (VBP do) (`` ') (RB t) (VP (VB put) (PRT (RP out)) (NP (NNS data)))))) (, ,) (NP (NNS people)) (VP (MD will) (VP (VB say) (, ,) (WHADVP (WRB why)) (SQ (VBP are) (NP (PRP you)) (VP (VBG withholding) (NP (DT the) (NNS data)))))) (. ?)))
53: (ROOT (S (NP (NNS People)) (VP (VBP are) (VP (VBG trading) (PP (IN without) (S (VP (VBG knowing) (NP (DT the) (NNS data))))))) (. .)))
54: (ROOT (S (IN So) (S (NP (NP (PRP it))) (VP (VBZ 's) (NP (DT a) (JJ tough) (NN situation)) (S (VP (TO to) (VP (VB be) (VP (VBG doing) (NP (NN science)) (PP (IN in)))))))) (, ,) (CC and) (S (NP (PRP we)) (VP (VBP have) (NP (DT no) (NN choice)) (SBAR (IN because) (S (NP (PRP we)) (VP (VBP 're) (VP (VBG trying) (S (VP (TO to) (VP (VB develop) (NP (DT a) (NN vaccine))))))))))) (. .) ('' ')))
55: (ROOT (S (S (PP (IN With) (NP (NP (ADJP (RB so) (JJ many)) (JJ different) (NNS interests)) (VP (VP (VBG demanding) (NP (DT the) (JJS latest) (NN information))) (: -) (PP (VBG including) (NP (NP (NNS governments)) (PP (IN around) (NP (DT the) (NN world))))) (: -)))) (NP (DT the) (NN company)) (VP (MD could) (`` ') (RB t) (VP (VB withhold) (NP (PRP it)) (PP (IN from) (NP (DT the) (NN public)))))) (, ,) (NP (PRP he)) (VP (VBD said)) (. .)))
56: (ROOT (S (PP (IN As) (NP (DT a) (JJ public) (NN company))) (, ,) (SBAR (IN if) (S (NP (PRP we)) (VP (VBP have) (NP (PRP it))))) (, ,) (NP (PRP we)) (VP (MD can) (RB not) (VP (VP (VB give) (NP (DT this)) (PP (IN to) (NP (PRP them)))) (CC and) (VP (VB hide) (NP (PRP it)) (PP (IN from) (NP (JJ other) (NNS people)))))) (. .) ('' ')))
57: (ROOT (S (NP (NNP D.) (NNP Fauci)) (VP (VBD said) (SBAR (IN that) (S (S (NP (NNS whilecompanies)) (ADVP (RB often)) (VP (VBP release) (NP (JJ partial) (NNS data)))) (, ,) (`` `) (NP (PRP$ My) (JJ own) (NN preference)) (, ,) (CC and) (SBAR (WHNP (WP what)) (S (NP (PRP$ my) (NN group)) (VP (MD will) (VP (VB do))))) (, ,) (VP (MD will) (VP (VB be) (S (VP (TO to) (VP (VP (VB wait) (SBAR (IN until) (S (NP (PRP we)) (VP (VBP get) (S (NP (DT the) (NNS data)) (ADJP (JJ solid))))))) (CC and) (ADVP (RB then)) (VP (VB publish) (NP (PRP it)) (PP (IN in) (NP (NP (DT a) (NN paper)) (VP (VBG saying) (, ,) (`` `) (S (PP (IN In) (NP (DT the) (JJ first) (NN phase))) (NP (DT this)) (VP (VBZ is) (SBAR (WHNP (WP what)) (S (NP (PRP we)) (VP (VBD saw)))))))))))))))))) (. .)))
58: (ROOT (S ('' '') (ADVP (RB Still)) (, ,) (NP (PRP he)) (VP (VBZ considers) (S (NP (NP (NNP Moderna) (POS 's)) (JJ preliminary) (NNS results)) (ADJP (JJ encouraging)))) (. .)))
59: (ROOT (S (S (NP (NP (DT The) (NNS levels)) (PP (IN of) (NP (VBG neutralizing) (NNS antibodies))) (PP (IN in) (NP (NP (DT the) (CD eight) (NNS people)) (VP (VBN tested) (PP (IN for) (NP (PRP them))))))) (VP (VBD appeared) (S (ADJP (JJ high) (RB enough) (S (VP (TO to) (VP (VB be) (ADJP (JJ protective))))))))) (, ,) (NP (NNP D.) (NNP Fauci)) (VP (VBD said)) (. .)))
60: (ROOT (S (CC But) (NP (PRP he)) (VP (VBD emphasized) (SBAR (IN that) (S (NP (CD eight)) (VP (VBZ is) (NP (DT a) (JJ small) (NN number)))))) (. .)))
61: (ROOT (S (`` `) (S (NP (PRP I)) (VP (VBP have) (S (VP (TO to) (VP (VB underscore) (SBAR (S (NP (PRP it)) (VP (VBZ 's) (ADVP (RB still)) (ADJP (VBN limited)))))))))) (PRN (PRN (, ,) ('' ') (S (NP (PRP he)) (VP (VBD said))) (, ,)) ('' `)) (CC and) (S (S (NP (DT that)) (VP (VBZ 's) (NP (NP (DT the) (NN reason)) (SBAR (WHADVP (WRB why)) (S (NP (PRP I)) (ADVP (RB just)) (VP (VBP withhold) (NP (PRP$ my) (NN enthusiasm)))))))) (, ,) (CC but) (S (NP (PRP I)) (ADVP (RB still)) (VP (VBP have) (NP (DT some) (JJ cautious) (NN optimism))))) (. .) ('' ')))
62: (ROOT (S (NP (NNP D.) (NNP Fauci)) (VP (VBD said) (SBAR (S (NP (DT the) (JJ big) (NN question)) (VP (VP (VBD remained)) (: :) (SQ (SQ (MD Will) (NP (DT the) (NN vaccine)) (VP (VB work))) (. ?))))))))
63: (ROOT (S ('' `) (SBAR (WHADVP (WRB When)) (S (NP (PRP you)) (VP (VBP 're) (VP (VBG developing) (NP (DT a) (NN vaccine)))))) (PRN (, ,) ('' ') (S (NP (PRP he)) (VP (VBD said))) (, ,)) (`` `) (NP (NN nothing)) (VP (VBZ is) (VP (VBN guaranteed))) (. .) ('' ')))
64: (ROOT (S (NP (NNP Moderna)) (VP (VBZ is) (RB not) (NP (NP (DT the) (JJ only) (NN company)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (VP (VBN failed) (S (VP (TO to) (VP (VB release) (NP (JJ detailed) (JJ scientific) (NNS data))))))))))) (. .)))
65: (ROOT (S (NP (JJ Little)) (VP (VBZ has) (VP (VBN been) (VP (VBN known) (PP (IN about) (NP (NP (DT another) (ADJP (RB closely) (VBN watched)) (NN product)) (, ,) (NP (NP (NN remdesivir)) (, ,) (NP (NP (NP (DT an) (JJ experimental) (NN treatment)) (PP (IN for) (NP (CD Covi-19)))) (VP (VBN developed) (PP (IN by) (NP (NP (DT the) (NN drugmaker)) (NP (NNP Gilead)))))))))))) (. .)))
66: (ROOT (S (PP (IN On) (NP (NNP April) (CD 29))) (, ,) (NP (NNP Gilead)) (VP (VBD announced) (SBAR (IN that) (S (NP (PRP it)) (VP (VBD was) (ADJP (`` `) (JJ aware) (PP (IN of) (NP (NP (JJ positive) (NNS data)) ('' ') (PP (IN about) (NP (NP (NP (NNP remdesivir) (POS 's)) (NN performance)) (PP (IN in) (NP (DT a) (JJ federal) (NN trial)))))))))))) (. .)))
67: (ROOT (S (ADVP (NP (DT A) (JJ few) (NNS hours)) (RB later)) (, ,) (PP (IN from) (NP (DT the) (NNP Oval) (NNP Office))) (, ,) (NP (NNP D.) (NNP Fauci)) (VP (VBD said) (SBAR (S (NP (DT the) (NN drug)) (VP (MD could) (ADVP (RB modestly)) (VP (VB speed) (NP (NP (NN recovery)) (PP (IN in) (NP (NNS patients))))))))) (. .)))
68: (ROOT (S (SBAR (IN Although) (S (NP (PRP he)) (VP (VBD said) (SBAR (S (NP (PRP it)) (VP (VBD was) (RB not) (NP (DT a) (`` `) (NN knockout)))))))) (, ,) ('' ') (NP (NP (NNP D.) (NNP Fauci)) (PRN (: -) (S (NP (PRP$ his) (NN agency)) (VP (VBD ran) (NP (DT that) (NN trial)) (, ,) (ADVP (RB too)))) (: -))) (VP (VBD said) (SBAR (S (NP (DT the) (NN drug)) (VP (MD could) (VP (VB become) (NP (NP (DT the) (NN standard)) (PP (IN of) (NP (NN care))))))))) (. .)))
69: (ROOT (S (ADVP (NP (DT A) (JJ few) (NNS days)) (RB afterward)) (, ,) (NP (DT the) (NML (NNP Food) (CC and) (NNP Drug)) (NNP Administration)) (VP (VBD granted) (NP (NN emergency) (NN authorization) (S (VP (TO to) (VP (VB use) (NP (NN remdesivir)) (S (VP (TO to) (VP (VB treat) (NP (CD Covi-19)))))))))) (. .)))
70: (ROOT (S (NP (NNS Weeks)) (VP (VBD passed) (PP (IN with) (NP (NP (NP (DT no) (JJ detailed) (NNS data)) (PP (IN about) (NP (DT the) (JJ clinical) (NN trial)))) (VP (VBG being) (VP (VBN published))))) (, ,) (SBAR (ADVP (RB even)) (IN though) (S (NP (NNS doctors)) (VP (VBD were) (VP (VBG administering) (NP (DT the) (NN drug)) (PP (IN with) (NP (NP (JJ little) (NN information)) (SBAR (S (VP (TO to) (VP (VB guide) (NP (PRP them))))))))))))) (. .)))
71: (ROOT (SINV (`` `) (S (NP (PRP It)) (VP (VBD was) (NP (NP (DT a) (ADJP (RB highly) (JJ conflicted)) (NN statement)) (PP (IN from) (NP (DT a) (ADJP (ADJP (RB highly) (JJ respected)) (CC and) (ADJP (RB deservedly) (VBN respected))) (NN scientist)))))) (, ,) ('' ') (VP (VBD said)) (NP (NP (NNP Gary) (NNP Schwitzer)) (, ,) (NP (NP (DT the) (NN publisher)) (PP (IN of) (NP (NNP HealthNewsReview))))) (. .)))
72: (ROOT (NP (NP (NNP Org)) (, ,) (NP (NP (DT a) (NN watchdog) (NN publication)) (SBAR (WHNP (WDT that)) (S (VP (VBZ argues) (PP (IN for) (NP (ADJP (RBR more) (JJ accurate)) (NN science) (NN journalism))))))) (. .)))
73: (ROOT (S (RB So) (NP (PRP it)) (VP (VBZ brings) (NP (PRP you)) (ADVP (RB back)) (PP (IN to) (, ,) (SBARQ (WHNP (WP what)) (SQ (VBP do) (NP (PRP we)) (VP (VB believe)))))) (. ?)))
74: (ROOT (SBARQ (WHNP (WP Whom)) (SQ (VBP do) (NP (PRP we)) (VP (VB believe))) (. ?) ('' ')))
75: (ROOT (S (NP (NNP D.) (NNP Fauci)) (VP (VBD said) (SBAR (S (NP (NP (PRP he)) (CC and) (NP (PRP$ his) (NN research) (NN team))) (VP (VBD decided) (TO to) (VP (VB report) (NP (DT some) (NNS results)) (SBAR (WHADVP (WRB when)) (S (S (NP (DT the) (NN study)) (VP (VBD was) (VP (VBN stopped)))) (SBAR (IN after) (S (NP (DT an) (JJ independent) (NN safety) (NN board)) (VP (VBD found) (SBAR (IN that) (S (NP (DT the) (VBN treated) (NNS patients)) (VP (VBD were) (VP (VBG recovering) (ADVP (ADVP (RBR faster)) (PP (IN than) (NP (NP (DT those)) (VP (VBG receiving) (NP (NNS placebos)))))))))))))))))))) (. .)))
76: (ROOT (S (PP (IN For) (NP (JJ ethical) (NNS reasons))) (, ,) (NP (DT all) (NNS patients)) (VP (VBD had) (S (VP (TO to) (VP (VB be) (VP (VBN offered) (NP (DT the) (NN drug))))))) (. .)))
77: (ROOT (S (NP (DT The) (NN information)) (VP (MD would) (ADVP (RB likely)) (VP (VB have) (VP (VBN leaked) (PRT (RP out)) (, -) (PP (ADVP (RB especially)) (VBN given) (SBAR (IN that) (, ,) (S (ADVP (NP (CD two) (NNS weeks)) (RBR earlier)) (, ,) (NP (NP (NN information)) (PP (IN from) (NP (DT another) (NN remdesivir) (NN trial)))) (VP (VBD had) (VP (VBN been) (VP (VBN disclosed) (PP (IN to) (NP (NP (DT the) (NN news) (NN site)) (NNP STAT))) (, ,) (S (VP (VBG sending) (NP (NP (NNP Gilead) (POS 's)) (NN stock)) (PRT (RP up))))))))))))) (. .)))
78: (ROOT (S (NP (NNP D.) (NNP Fauci)) (VP (VBD announced) (SBAR (IN that) (S (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NN remdesivir))))) (VP (VBD recovered) (PP (PP (IN in) (NP (CD 11) (NNS days))) (, ,) (PP (VBN compared) (PP (IN with) (NP (NP (CD 15) (NNS days)) (PP (IN for) (NP (NP (DT those)) (VP (VBG getting) (NP (NNS placebos))))))))))))) (. .)))
79: (ROOT (S (`` `) (S (NP (DT That)) (VP (VBD was) (NP (NP (PDT all) (DT the) (NNS data)) (SBAR (S (NP (PRP we)) (VP (VBD had))))))) (, ,) ('' ') (NP (PRP he)) (VP (VBD said)) (. .)))
80: (ROOT (S (NP (DT The) (JJ full) (NNS results)) (VP (VBD were) (VP (VBN published) (PP (IN on) (NP (NNP Friday))) (PP (IN in) (NP (NP (DT The) (NML (NNP New) (NNP England)) (NNP Journal)) (PP (IN of) (NP (NNP Medicine))))))) (. .)))
81: (ROOT (S (NP (NP (DT The) (JJ fast) (NN pace)) (PP (IN of) (NP (NN research)))) (VP (VBZ has) (VP (VBN caught) (NP (JJ many) (NN news) (NNS organizations)) (PP (IN off) (NP (NN guard))) (, ,) (S (VP (VBG prompting) (NP (NP (NML (NN cas) (HYPH -) (NN b) (HYPH -) (NN case)) (NNS discussions)) (PP (IN on) (NP (NP (JJ tight) (NNS deadlines)) (SBAR (S (VP (TO to) (VP (VB decide) (SBAR (IN whether) (: -) (CC and) (WRB how) (: -) (S (VP (TO to) (VP (VB cover) (NP (JJ scientific) (NN news)) (SBAR (WHADVP (RB even) (WRB when)) (S (NP (NP (DT the) (NN quality)) (PP (IN of) (NP (NNS studies)))) (VP (MD would) (VP (`` ') (RB t) (ADVP (RB normally)) (VP (VB meet) (NP (PRP$ their) (NNS standards)))))))))))))))))))))) (. .)))
82: (ROOT (S (NP (JJ Scientific) (NNS articles)) (ADVP (RB normally)) (VP (VBP take) (NP (NNS months)) (S (VP (TO to) (VP (VB go) (PP (IN through) (NP (NN peer) (NN review))))))) (. .)))
83: (ROOT (S (CC But) (ADVP (RB now)) (, ,) (NP (JJ many) (NNS papers)) (VP (VBP are) (VP (VBG being) (VP (VBN published) (PP (IN on) (NP (NP (JJ preprint) (NNS servers)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (NNS scientists)) (VP (VBP are) (VP (VBG posting) (NP (NN research)) (SBAR (IN before) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN accepted) (PP (IN by) (NP (DT a) (NN journal)))))))))))))))) (. .)))
84: (ROOT (S (NP (NP (DT The) (NN site) (NNP medRxiv)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN founded) (NP (JJ last) (NNP June)))))) (, ,)) (VP (VP (VBD had) (NP (QP (CD 10) (CD million)) (NNS views)) (PP (IN in) (NP (NNP April)))) (CC and) (VP (VBZ has) (VP (VBN posted) (NP (NP (QP (RB nearly) (CD ,) (CD 100)) (NNS papers)) (VP (VBN related) (PP (IN to) (NP (CD Covi-19))))) (PP (IN since) (NP (NNP January)))))) (. .)))
85: (ROOT (S (NP (NP (DT A) (JJ similar) (NN site)) (, ,) (NP (NNP bioRxiv)) (, ,)) (VP (VBZ has) (VP (VBN posted) (NP (NP (QP (RB about) (CD 760)) (NNS papers)) (PP (IN on) (NP (DT the) (NN virus)))))) (. .)))
86: (ROOT (SINV (`` `) (S (NP (NNS People)) (VP (VBD recognized) (SBAR (IN that) (S (NP (EX there)) (VP (VBD was) (NP (DT an) (JJ urgent) (NN need) (S (VP (TO to) (VP (VB disseminate) (NP (NN information))))))))))) (, ,) ('' ') (VP (VBD said)) (NP (NP (NNP D.) (NNP Harlan) (NNP Krumholz)) (, ,) (NP (NP (DT a) (NML (NML (NN cardiologist)) (CC and) (NML (NML (NN health) (NN care)) (NN researcher)))) (PP (IN at) (NP (NNP Yale) (NNP University)))) (, ,) (CC and) (NP (NP (DT a) (NN c) (HYPH -) (NN founder)) (PP (IN of) (NP (NNP medRxiv))))) (. .)))
87: (ROOT (SBAR (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN pronounced) (S (`` `) (NP (NN med) (NN archive))))))) (. .) ('' ')))
88: (ROOT (S (NP (NNS People)) (VP (VBD recognized) (SBAR (IN that) (S (NP (RB even) (NNS weeks)) (VP (VBP matter) (PP (IN in) (NP (NP (DT this) (NN moment)) (SBAR (WHADVP (WRB when)) (S (NP (PRP we)) (VP (VBP do) (`` ') (RB t) (VP (VB know) (ADVP (RB very) (JJ much)))))))))))) (. .) ('' ')))
89: (ROOT (S (S (VP (VBN Asked) (PP (IN about) (NP (NN criticism) (SBAR (IN that) (S (NP (NP (NNS sites)) (PP (IN like) (NP (NNP medRxiv)))) (VP (VBP encourage) (NP (NP (DT the) (JJ rash) (NN publication)) (PP (IN of) (NP (JJ bad) (NN science))))))))))) (, ,) (NP (NNP D.) (NNP Krumholz)) (VP (VP (VBD said) (SBAR (S (NP (DT these) (NNS conversations)) (VP (VBD were) (ADJP (JJ healthy)))))) (CC and) (VP (VBD noted) (SBAR (IN that) (S (NP (NP (NNS articles)) (PP (IN in) (NP (ADJP (NN pee) (HYPH -) (VBN reviewed)) (NNS journals)))) (VP (MD could) (ADVP (RB also)) (VP (VB be) (ADJP (JJ flawed)))))))) (. .)))
90: (ROOT (S (NP (NNS Submissions)) (VP (VBP go) (PP (IN through) (NP (JJ basic) (NN vetting))) (S (VP (TO to) (VP (VB ensure) (SBAR (S (NP (DT the) (NN research)) (VP (VBZ is) (ADJP (JJ legitimate))))))))) (. .)))
91: (ROOT (S (`` `) (S (VP (VB Engage) (PP (IN in) (SBAR (IN whether) (S (S (NP (PRP it)) (VP (VBZ 's) (NP (JJ good) (NN science)))) (CC or) (RB not)))))) (, ,) ('' ') (NP (PRP he)) (VP (VBD said)) (. .)))
92: (ROOT (S (VP (VB Let) (S (NP (PRP 's)) (VP (VB engage) (PP (IN in) (NP (NP (DT the) (NNS consequences)) (PP (IN of) (NP (DT this)))))))) (. .) ('' ')))
93: (ROOT (S (NP (NP (NP (DT The) (NN post)) (SBAR (WHADJP (WRB How) (JJ Upbeat)) (S (NNP Vaccine) (NNP News) (VP (VBD Fueled) (NP (DT a) (NNP Stock) (NNP Surge)))))) (, ,) (CC and) (NP (DT an) (NNP Uproar))) (VP (VBD appeared) (ADVP (RB first)) (PP (IN on) (NP (NML (NNP New) (NNP York)) (NNP Times)))) (. .)))
